Generali


First take: good signals from the life business

17/11/23 -"The results were in line for Generali, with good signals from the Life business. The impact on life CSM from the revised customer lapse assumption is lower, and the CSM contribution is still strong ..."

Pages
55
Language
English
Published on
17/11/23
You may also be interested by these reports :
20/11/26
18 months ago, our positive recommendation on NN (ADD; Netherlands) rested on its valuation, reflected in its high shareholder return yield, while ...

19/11/26
We have updated our forecasts following the release of Munich Re’s 3Q26 results. As anticipated after last October’s preliminary release, the group’s ...

18/11/26
Allianz reported strong results, ahead of market expectations, and raised its FY26 outlook. We have revised our assumptions and upgraded our ...

17/11/26
L&G has released its first-ever trading update. The key takeaway, in our view, was the weakness of volumes in UK PRT, L&G’s core business. There have ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO